Search results
Results from the WOW.Com Content Network
John Nath Kapoor (born 1942/1943) is an American multi-millionaire, pharmaceutical entrepreneur, former CEO of Insys Therapeutics, and majority shareholder in the generic drug manufacturing company Akorn. [2]
Ricci has spent his entire technology career in the pharmaceutical industry, beginning at Bristol-Myers Squibb, then Johnson & Johnson, Novartis, and Shire. He joined Takeda after it acquired ...
John C. Reed (born October 11, 1958) is executive vice president of pharmaceutical research and development at Johnson & Johnson.He was previously the executive vice president and global head of research and development of Sanofi, the global head of pharmaceutical research and early development at Roche, and the chief executive of the Sanford-Burnham Medical Research Institute in La Jolla, San ...
Insys Therapeutics Company type Public Traded as Nasdaq: INSY Industry Pharmaceutical Founded 1990 ; 35 years ago (1990) Founder John Kapoor Fate Bankrupt (2019) Headquarters Chandler, Arizona, U.S. Key people Michael Babich (CEO) Products Subsys (fentanyl) Syndros (Tetrahydrocannabinol) Number of employees 343 (2019) Insys Therapeutics was an American specialty pharmaceutical company based in ...
Get breaking news and the latest headlines on business, entertainment, politics, world news, tech, sports, videos and much more from AOL
The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024. If approved, the new plan would end ...
J. Michael Pearson (born 1959) is a Canadian American [1] pharmaceutical company executive. He is the former chairman and CEO of Valeant Pharmaceuticals International [2] [3] after being ousted in the aftermath of a report on pharmaceutical pricing published by Citron Research in April 2016.
It provides daily news and analysis on the biotechnology and pharmaceutical industry including areas such as policy & regulation, business news, research & development, generics, drug delivery, and clinical trials. In 2022, Informa sold its Pharma Intelligence division, including Scrip, to Warburg Pincus. [4] The business was renamed Citeline.